| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $24,750,816 ) (Continued on the next page) |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01MH125720 | Biopsychosocial Phenotypes and Potential Mechanisms in CHARTER | 001 | 4 | NIH | 11/20/2023 | $122,093 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01EY025872 | Adaptive population codes for flexible visually-guided behaviors | 000 | 14 | NIH | 11/30/2023 | $395,000 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01ES033636 | Investigating neurodevelopmental toxicity of perfluoroalkyl acids and their derivatives in human brain organoids models | 000 | 3 | NIH | 11/29/2023 | $602,132 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01ES032547 | Detecting Mutational Signatures of Environmental Mutagens in Heathy Individuals for Personalized Cancer Prevention | 000 | 4 | NIH | 10/31/2023 | $681,334 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01DK126848 | Investigating Syndecan-1 in Hepcidin Regulation and Iron Metabolism | 000 | 4 | NIH | 11/15/2023 | $544,295 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01DK124298 | ANT2 in metaflammation and insulin resistance | 000 | 4 | NIH | 11/28/2023 | $355,501 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01AI179952 | Tissue-specific adaptions to promote localized T cell memory | 000 | 1 | NIH | 11/9/2023 | $554,754 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01AI176639 | Innate immunity against viral infection in intestinal epithelial cells of C. elegans | 000 | 2 | NIH | 12/7/2023 | $348,124 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | F32HD108944 | Probing and modeling decidual natural killer cells in preterm birth | 000 | 2 | NIH | 10/27/2023 | $70,082 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01AI169892 | Defining the resistome in P. falciparum: evolution and mechanism | 000 | 2 | NIH | 10/23/2023 | $992,328 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01DK074482 | Molecular and functional dissection of the zebrafish hematopoietic stem cell niche | 000 | 18 | NIH | 11/20/2023 | $381,507 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01AI151004 | Precision guided SIT for the control of vector-borne disease | 000 | 5 | NIH | 12/7/2023 | $415,756 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | F32CA265052 | The role of sympathetic nerve associated macrophages during pancreatic adenocarcinoma progression | 000 | 3 | NIH | 11/22/2023 | $2,500 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | F32AT011475 | A Genomic Approach to Discovering Novel Cathepsin Inhibitors from Cyanobacteria | 000 | 3 | NIH | 11/17/2023 | $72,000 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01AI145314 | Molecular Mechanisms Underlying Dendritic Cell Adaptations During Chronic Infection | 000 | 5 | NIH | 11/30/2023 | $434,067 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | F31DC021854 | Effects of late first language acquisition on phonological processing in American Sign Language | 000 | 1 | NIH | 12/6/2023 | $40,503 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | F31AI176705 | Understanding Prostate Resident Memory T Cells | 000 | 1 | NIH | 11/22/2023 | $40,286 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01AG081037 | Reversing Microglial Inflammarafts and Mitochondrial Dysfunction in Alzheimer's Disease | 000 | 2 | NIH | 12/7/2023 | $703,428 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | F30AI176696 | Investigating the mechanism of infection and therapeutic potential of Pseudomonas nucleus-forming phages | 000 | 1 | NIH | 12/6/2023 | $40,386 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01CA271104 | Evaluation of a telehealth oncofertility care intervention in adolescent and young adult cancer patients: a stepped wedge cluster randomized controlled trial | 000 | 2 | NIH | 11/16/2023 | $559,090 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01AG077579 | Understanding Biological and Lifestyle Contributions to Alzheimer's Disease Pathology and Clinical Profiles in Black Women: Defining Prevention Targets in High Risk Groups | 001 | 2 | NIH | 11/9/2023 | $82,873 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01CA247551 | Co-targeting the HER3 oncogenic signaling circuitry and PD-1 as a novel multimodal precision immunotherapy for HNSCC | 000 | 5 | NIH | 11/30/2023 | $449,975 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01AG077579 | Understanding Biological and Lifestyle Contributions to Alzheimer's Disease Pathology and Clinical Profiles in Black Women: Defining Prevention Targets in High Risk Groups | 000 | 2 | NIH | 11/6/2023 | $702,587 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01CA226909 | Therapeutic Targeting of Macrophage PI3Kgamma in HNSCC | 001 | 6 | NIH | 12/7/2023 | $522,215 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01AG077202 | COVID-19-related blood-brain barrier and microstructural brain injury; Sex differences and synergy with Alzheimer's disease risk | 000 | 2 | NIH | 11/21/2023 | $703,067 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R03DK138495 | Gene regulatory programs drivingmetabolic maturation of human pluripotent stem cell derived ?-cells | 000 | 1 | NIH | 12/7/2023 | $158,000 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01MD014850 | iGLAMOUR Study: Innovations in Glaucoma Adherence and monitoring Of Under-Represented minorities | 000 | 4 | NIH | 12/6/2023 | $269,942 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01GM148607 | Mechanism of Energy Transduction and Substrate Activation in Biological Nitrogen Fixation | 000 | 2 | NIH | 11/1/2023 | $279,352 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R03CA287274 | Profiling Epitranscriptomic RNA editing in Pediatric Cancer | 000 | 1 | NIH | 11/30/2023 | $158,000 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01MD014850 | iGLAMOUR Study: Innovations in Glaucoma Adherence and monitoring Of Under-Represented minorities | 000 | 4 | NIH | 12/6/2023 | $202,500 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R37CA215081 | Elucidation and therapeutic exploitation of PAK mediated radioresistance | 000 | 7 | NIH | 11/13/2023 | $325,283 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01NS124585 | Multimodal imaging of memory in epilepsy from whole brain networks to local neuronal responses: Implications for surgical decision-making | 000 | 3 | NIH | 11/20/2023 | $726,274 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R35NS097265 | Resilient versus fragile aspects of blood flow in the mammalian brain | 000 | 8 | NIH | 11/29/2023 | $802,067 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01NS121070 | Mechanisms of hypoxia induced exacerbation of cerebral cavernous malformations | 000 | 3 | NIH | 11/9/2023 | $418,500 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01NS119615 | How do CNS fibroblasts regulate the response to neuroinflammation? | 000 | 4 | NIH | 12/7/2023 | $397,238 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R35GM139645 | Charge matters: Pursuing the most common, and least understood molecular interactions in cells | 000 | 4 | NIH | 11/17/2023 | $497,700 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01HL163931 | Endothelial Cytoprotective Signaling by Activated Protein C/Protease-activated Receptor-1 | 001 | 2 | NIH | 11/17/2023 | $114,585 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R35GM134970 | Maintenance and Repair of the C. elegans Skin | 000 | 5 | NIH | 11/10/2023 | $355,499 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R25NS119707 | Preparing Diverse Transfer Students for Research Careers in Neuroscience | 000 | 4 | NIH | 11/29/2023 | $258,628 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R24MH129166 | CHARTER Plus: A resource for cutting-edge research on neurological function and mental health in people with HIV and substance use disorders across the lifespan | 000 | 3 | NIH | 12/5/2023 | $500,000 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01HL163931 | Endothelial Cytoprotective Signaling by Activated Protein C/Protease-activated Receptor-1 | 000 | 2 | NIH | 11/16/2023 | $542,785 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R24MH129166 | CHARTER Plus: A resource for cutting-edge research on neurological function and mental health in people with HIV and substance use disorders across the lifespan | 000 | 3 | NIH | 12/5/2023 | $580,078 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01NS116373 | Mechanistic analysis of microtubule dynamics and stability in neurons | 000 | 4 | NIH | 12/5/2023 | $301,932 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01NS111162 | Molecular and Cellular Mechanisms Underlying Activity Dependent Gene Regulation in Neurons | 000 | 5 | NIH | 11/20/2023 | $298,530 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | UM1AI069536 | HIV Centers for Underrepresented Populations in Research Clinical Trials Unit (CURE CTU) | 000 | 18 | NIH | 10/27/2023 | $31,158 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | UM1AI069536 | HIV Centers for Underrepresented Populations in Research Clinical Trials Unit (CURE CTU) | 000 | 18 | NIH | 10/27/2023 | $961,636 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | UM1AI069432 | UCSD Collaborative Clinical Trials Unit | 000 | 18 | NIH | 11/8/2023 | $512,143 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | UM1AI069432 | UCSD Collaborative Clinical Trials Unit | 000 | 18 | NIH | 11/8/2023 | $1,281,365 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DRIVE | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01DK135289 | Development of caspase-6 inhibitors for treatment of NASH | 000 | 2 | NIH | 11/10/2023 | $629,832 |
|
